Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cancer Prevention02:59

Cancer Prevention

6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials.

International journal of molecular sciences·2026
Same author

Sex differences in MASLD-related atherosclerosis: plaque phenotype, vascular dysfunction, and cardiovascular outcomes.

Biology of sex differences·2026
Same author

Die hard: when cells refuse apoptosis-the rise of paraptosis and other death pathways.

Cell death discovery·2026
Same author

Micro-Nanoplastic Exposure and Lung Cancer Biomarkers: The Role of Extracellular Vesicle-Mediated Intercellular Communication.

International journal of molecular sciences·2026
Same author

Cell-specific Y-box-binding protein-1 drives liver-kidney injury in cholestasis.

American journal of physiology. Renal physiology·2026
Same author

Altered global longitudinal strain is a common finding in liver transplant recipients with mild cardiometabolic burden.

Internal and emergency medicine·2026

Related Experiment Video

Updated: Jun 3, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K

Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development.

Nevena Todorovic1,2, Serena Martinelli1, Giulia Nannini1

  • 1Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

International Journal of Molecular Sciences
|January 8, 2025
PubMed
Summary

The gut microbiota influences chronic liver diseases, including viral hepatitis and non-alcoholic fatty liver disease. Microbial imbalances contribute to liver damage, cirrhosis, and hepatocellular carcinoma (HCC) development.

Keywords:
cirrhosisfibrosisgut microbiotahepatocellular carcinomaoncobiomesteatosis

More Related Videos

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.2K

Related Experiment Videos

Last Updated: Jun 3, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.1K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.2K
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
08:40

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

6.2K

Area of Science:

  • Microbiology and Hepatology
  • Gut-liver axis research
  • Oncovirome in cancer development

Background:

  • Chronic liver disease involves inflammation, damage, and regeneration, progressing to cirrhosis and hepatocellular carcinoma (HCC).
  • Gut microbiota plays a crucial role in health, and its dysbiosis is linked to various pathologies, including chronic liver diseases.
  • Intratumoural microbiota, or the 'oncobiome,' is increasingly recognized for its impact on HCC development and progression.

Purpose of the Study:

  • To review the influence of gut microbiota on viral hepatitis (Hepatitis B and C) progression.
  • To explore microbial dysbiosis in non-alcoholic fatty liver disease (NAFLD) and its silent progression.
  • To examine alcohol's impact on the liver and its interaction with microbiota, linking inflammation to cirrhosis and cancer.

Main Methods:

  • Literature review of existing research on microbiota and liver disease.
  • Analysis of studies focusing on viral hepatitis, NAFLD, and alcohol-related liver disease.
  • Exploration of the oncobiome's role in hepatocellular carcinoma (HCC) pathogenesis.

Main Results:

  • Gut microbiota significantly shapes the progression of liver disease in viral hepatitis.
  • Microbial dysbiosis is a key factor in the silent and dangerous progression of NAFLD.
  • Alcohol-induced liver injury involves complex interactions with the gut microbiota, contributing to cirrhosis and HCC.

Conclusions:

  • The gut microbiota is a critical determinant in the pathogenesis of various chronic liver diseases.
  • Understanding the oncobiome offers new insights into hepatocellular carcinoma development.
  • Targeting microbial dysbiosis presents potential therapeutic strategies for liver disease and HCC prevention.